CYBN.NE
Price:
$14
Market Cap:
$279.89M
Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to treat neuroinflammation. It has also developed EMBARK, a psychedelic-assisted psychotherapy. The company is headquartered in Toronto, Canada.[Read more]
Industry
Biotechnology
IPO Date
2020-11-10
Stock Exchange
NEO
Ticker
CYBN.NE
According to Cybin Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 96.82M. This represents a change of -34.56% compared to the average of 147.96M of the last 4 quarters.
The mean historical Enterprise Value of Cybin Inc. over the last ten years is 22.64M. The current 96.82M Enterprise Value has changed 42.67% with respect to the historical average. Over the past ten years (40 quarters), CYBN.NE's Enterprise Value was at its highest in in the September 2021 quarter at 385.70M. The Enterprise Value was at its lowest in in the December 2019 quarter at 0.
Average
22.64M
Median
24.63M
Minimum
-203933400.00
Maximum
133.47M
Discovering the peaks and valleys of Cybin Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 265.42%
Maximum Annual Enterprise Value = 133.47M
Minimum Annual Increase = -3041.25%
Minimum Annual Enterprise Value = -203933400.00
Year | Enterprise Value | Change |
---|---|---|
2024 | -203933400.00 | -344.24% |
2023 | 83.50M | -21.68% |
2022 | 106.61M | -20.13% |
2021 | 133.47M | 265.42% |
2020 | 36.52M | 186.72% |
2019 | 12.74M | -3041.25% |
2018 | -433108.00 | -103.43% |
The current Enterprise Value of Cybin Inc. (CYBN.NE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-4609293.67
5-year avg
31.23M
10-year avg
22.64M
Cybin Inc.’s Enterprise Value is greater than Red Light Holland Corp. (731.12K), less than Mind Medicine (MindMed) Inc. (518.63M), greater than Revive Therapeutics Ltd. (248.56K), greater than HAVN Life Sciences Inc. (442.16K), greater than Numinus Wellness Inc. (11.43M),
Company | Enterprise Value | Market cap |
---|---|---|
731.12K | $13.97M | |
518.63M | $1.05B | |
248.56K | $1.05M | |
442.16K | $442.16K | |
11.43M | $8.06M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cybin Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cybin Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Cybin Inc.'s Enterprise Value?
What is the highest Enterprise Value for Cybin Inc. (CYBN.NE)?
What is the 3-year average Enterprise Value for Cybin Inc. (CYBN.NE)?
What is the 5-year average Enterprise Value for Cybin Inc. (CYBN.NE)?
How does the current Enterprise Value for Cybin Inc. (CYBN.NE) compare to its historical average?